Compile Data Set for Download or QSAR
Report error Found 196 Enz. Inhib. hit(s) with all data for entry = 11883
TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656886(US11919918, Compound C22)
Affinity DataIC50: 37nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656967(tert-butyl 2-(2- amino-5-((2- bromo-5- isopropylpy...)
Affinity DataIC50: 40nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656943(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4- cyc...)
Affinity DataIC50: 43nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656955(3-((2-amino-5- ((2-bromo-5- isopropylpyridin- 4-yl...)
Affinity DataIC50: 44nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656963(US11919918, Compound C214)
Affinity DataIC50: 44nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656884(US11919918, Compound C20)
Affinity DataIC50: 44.4nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656932(US11919918, Compound C154)
Affinity DataIC50: 46nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656936(US11919918, Compound C196 | 5-((2-methoxy- 5-(prop...)
Affinity DataIC50: 46nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656967(tert-butyl 2-(2- amino-5-((2- bromo-5- isopropylpy...)
Affinity DataIC50: 48nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656943(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4- cyc...)
Affinity DataIC50: 51nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656947(5-((2- (methylamino)-5- (prop-1-en-2- yl)pyridin-4...)
Affinity DataIC50: 53nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656893(5-(5- isopropyl-2- vinylpyridin-4- yl)oxy)pyrimidi...)
Affinity DataIC50: 55nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656955(3-((2-amino-5- ((2-bromo-5- isopropylpyridin- 4-yl...)
Affinity DataIC50: 56nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656880(US11919918, Compound C12)
Affinity DataIC50: 56.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656886(US11919918, Compound C22)
Affinity DataIC50: 57nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656972(2-((4-amino- 5-((2-ethynyl- 5-isopropyl- pyridin-4...)
Affinity DataIC50: 60nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656965(3-((2-amino-5-((2- ethynyl-5- isopropylpyridin- 4-...)
Affinity DataIC50: 62nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656960(2-((2-amino-5-((2- ethynyl-5- isopropylpyridin- 4-...)
Affinity DataIC50: 64nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656965(3-((2-amino-5-((2- ethynyl-5- isopropylpyridin- 4-...)
Affinity DataIC50: 65nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656971(3-((4-amino- 5-((2-ethynyl- 5-isopropyl- pyridin-4...)
Affinity DataIC50: 65nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656901(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4-(2- ...)
Affinity DataIC50: 67nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656947(5-((2- (methylamino)-5- (prop-1-en-2- yl)pyridin-4...)
Affinity DataIC50: 69nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656936(US11919918, Compound C196 | 5-((2-methoxy- 5-(prop...)
Affinity DataIC50: 71nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656963(US11919918, Compound C214)
Affinity DataIC50: 72nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656973(5-((2-ethynyl- 5-isopropyl- pyrdin-4-yl)oxy)- N2-i...)
Affinity DataIC50: 72nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656932(US11919918, Compound C154)
Affinity DataIC50: 72nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656901(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4-(2- ...)
Affinity DataIC50: 72nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656880(US11919918, Compound C12)
Affinity DataIC50: 73.6nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656957(5-((2- (methylthio)-5- (prop-1-en-2- yl)pyridin-4-...)
Affinity DataIC50: 75.3nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656884(US11919918, Compound C20)
Affinity DataIC50: 75.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656945(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4- iso...)
Affinity DataIC50: 78nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656904(US11919918, Compound C85)
Affinity DataIC50: 78nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656961(US11919918, Compound C212)
Affinity DataIC50: 81nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656931(2-((2-amino-5- ((2-bromo-5- isopropylpyridin- 4-yl...)
Affinity DataIC50: 83nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656945(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4- iso...)
Affinity DataIC50: 84nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656899(US11919918, Compound C66)
Affinity DataIC50: 85nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656975(2-((4-amino-5- ((2-bromo-5- isopropyl- pyridin-4- ...)
Affinity DataIC50: 88nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656869(US11919918, Compound C2)
Affinity DataIC50: 88.1nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656964(5-((2-ethynyl- 5-(prop-1-en- 2-yl)pyridin- 4-yl)ox...)
Affinity DataIC50: 88.2nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656902(US11919918, Compound C72)
Affinity DataIC50: 89nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656974(3-((4-amino-5- ((2-bromo-5- isopropyl- pyridin-4- ...)
Affinity DataIC50: 90nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656931(2-((2-amino-5- ((2-bromo-5- isopropylpyridin- 4-yl...)
Affinity DataIC50: 96nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656940(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4- iso...)
Affinity DataIC50: 100nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656871(US11919918, Compound C4)
Affinity DataIC50: 102nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656953(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N4-(2- ...)
Affinity DataIC50: 103nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656977(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N2- cyc...)
Affinity DataIC50: 104nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656909(2-((4-amino-5- ((2-bromo-5- isopropyl- pyridin-4- ...)
Affinity DataIC50: 104nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656957(5-((2- (methylthio)-5- (prop-1-en-2- yl)pyridin-4-...)
Affinity DataIC50: 106nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 2/3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656972(2-((4-amino- 5-((2-ethynyl- 5-isopropyl- pyridin-4...)
Affinity DataIC50: 106nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Beijing Tide Pharmaceutical Co.

US Patent
LigandPNGBDBM656978(5-((2-bromo-5- isopropylpyridin- 4-yl)oxy)-N2- iso...)
Affinity DataIC50: 107nMAssay Description:Cells were seeded into a poly-D-lysine-coated 384-well cell culture plate (Corning) at a density of 11,000 cells/well/25 μL of cell inoculation ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2024
Entry Details
US Patent

Displayed 1 to 50 (of 196 total ) | Next | Last >>
Jump to: